Agilon Health (AGL) Equity Average (2020 - 2026)

Agilon Health (AGL) has 7 years of Equity Average data on file, last reported at $154.1 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average fell 68.27% year-over-year to $154.1 million; the trailing twelve-month figure through Mar 2026 stood at $154.1 million (down 68.27% YoY), and the FY2025 full-year result was $298.8 million, down 47.2% from the prior year.
• Equity Average for Q1 2026 stood at $154.1 million, down from $216.4 million in the prior quarter.
• Across five years, Equity Average topped out at $1.1 billion in Q2 2022 and bottomed at $154.1 million in Q1 2026.
• The 5-year median for Equity Average is $682.2 million (2024), against an average of $719.0 million.
• The widest annual swing landed in 2022, when Equity Average soared 477.9%; it then sank 68.27% in 2026.
• A 5-year view of Equity Average shows it stood at $1.1 billion in 2022, then decreased by 27.91% to $766.3 million in 2023, then plunged by 31.76% to $522.9 million in 2024, then slumped by 58.62% to $216.4 million in 2025, then retreated by 28.8% to $154.1 million in 2026.
• The last three Equity Average figures came in at $154.1 million (Q1 2026), $216.4 million (Q4 2025), and $357.5 million (Q3 2025), per Business Quant data.

Peer Comparison